Cargando…
Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study
BACKGROUND: Chronic inflammation caused by ulcerative colitis (UC) causes a pro-neoplastic drive in the inflamed colon, leading to a markedly greater risk of invasive malignancy compared to the general population. Despite surveillance protocols, 50% of cases proceed to cancer before neoplasia is det...
Autores principales: | Beggs, Andrew D., Mehta, Samir, Deeks, Jonathan J., James, Jonathan D., Caldwell, Germaine M., Dilworth, Mark P., Stockton, Joanne D., Blakeway, Daniel, Pestinger, Valerie, Vince, Alexandra, Taniere, Phillipe, Iqbal, Tariq, Magill, Laura, Matthews, Glenn, Morton, Dion G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355942/ https://www.ncbi.nlm.nih.gov/pubmed/30473377 http://dx.doi.org/10.1016/j.ebiom.2018.11.034 |
Ejemplares similares
-
Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia
por: Beggs, Andrew D, et al.
Publicado: (2018) -
Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
por: Pestinger, Valerie, et al.
Publicado: (2020) -
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
por: Pestinger, Valerie, et al.
Publicado: (2020) -
Clinical-grade whole-genome sequencing and 3′ transcriptome analysis of colorectal cancer patients
por: Stodolna, Agata, et al.
Publicado: (2021) -
The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden
por: Hallam, Sally, et al.
Publicado: (2020)